A detailed history of Headlands Technologies LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 50 shares of FLGT stock, worth $1,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Holding current value
$1,117
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$19.09 - $22.57 $954 - $1,128
50 New
50 $0
Q4 2023

Feb 02, 2024

SELL
$23.64 - $30.27 $8,203 - $10,503
-347 Reduced 85.26%
60 $1,000
Q3 2023

Nov 09, 2023

SELL
$26.74 - $40.81 $40,992 - $62,561
-1,533 Reduced 79.02%
407 $10,000
Q2 2023

Aug 03, 2023

BUY
$28.52 - $40.7 $55,328 - $78,958
1,940 New
1,940 $71,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $676M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.